# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-044551
Filing Date
2024-10-31
Accepted
2024-10-31 16:06:05
Documents
86
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ardx-20240930.htm iXBRL | 10-Q | 1695139
2 | EX-10.2 | exhibit102-xhovionecommerc.htm | EX-10.2 | 293672
3 | EX-10.5 | exhibit105-xardelyxxfourth.htm | EX-10.5 | 130934
4 | EX-10.6 | exhibit106-xericfosteroffe.htm | EX-10.6 | 15951
5 | EX-31.1 | ardx-20240930xex311.htm | EX-31.1 | 9758
6 | EX-31.2 | ardx-20240930xex312.htm | EX-31.2 | 9780
7 | EX-32.1 | ardx-20240930xex321.htm | EX-32.1 | 6466
13 |  | ardx-20240930_g1.jpg | GRAPHIC | 75659
14 |  | image_0.jpg | GRAPHIC | 49118
| Complete submission text file | 0001628280-24-044551.txt |  | 8731333

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ardx-20240930.xsd | EX-101.SCH | 59004
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ardx-20240930_cal.xml | EX-101.CAL | 68516
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ardx-20240930_def.xml | EX-101.DEF | 261013
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ardx-20240930_lab.xml | EX-101.LAB | 698698
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ardx-20240930_pre.xml | EX-101.PRE | 479894
89 | EXTRACTED XBRL INSTANCE DOCUMENT | ardx-20240930_htm.xml | XML | 1087329

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 241415240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)